News & Articles

Join us on Monday, June 22, to learn how Olink’s latest immunoassay technology is taking proteomics to a new level

Your guide to choosing and implementing the best automated solutions for the clinical laboratory

Diagnostics for glycemic monitoring and ketosis testing on show

Participation will help advance liquid biopsy adoption by collaborating among key industry stakeholders

llumina's COVIDSeq aims to generate information about the genomic sequence of the virus

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work

Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

Highly specific prototype test detects the virus spike protein at clinically relevant concentrations

The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications

Our expert webinar series aims to help you get the most from your drug discovery research

The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19

This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic

CellaVision integration with HORIBA’s HELO automated hematology platform enables unique two-way data flow and rapid results validation

Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity

Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry